Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

Michallet, Mauricette; Dreger, Peter; Sobh, Mohamad; Koster, Linda; Hoek, Jennifer; Boumendil, Ariane; Scheid, Christof; Fox, Christopher P.; Wulf, Gerald; Krueger, William; van Gelder, Michel; Corradini, Paolo; Russo, Domenico; Passweg, Jakob; Schoemans, Helene; Bethge, Wolfgang; Schaap, Nicolaas; Cornelissen, Jan; Browne, Paul; Durakovic, Nadira; Muller, Lutz; Montoto, Silvia; Kroger, Nicolaus; Schetelig, Johannes

Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

Autor(en):

Michallet, Mauricette; Dreger, Peter; Sobh, Mohamad; Koster, Linda; Hoek, Jennifer; Boumendil, Ariane; Scheid, Christof; Fox, Christopher P.; Wulf, Gerald; Krueger, William; van Gelder, Michel; Corradini, Paolo; Russo, Domenico; Passweg, Jakob; Schoemans, Helene; Bethge, Wolfgang; Schaap, Nicolaas; Cornelissen, Jan; Browne, Paul; Durakovic, Nadira; Muller, Lutz; Montoto, Silvia; Kroger, Nicolaus; Schetelig, Johannes

Tübinger Autor(en):

Bethge, Wolfgang Andreas

Erschienen in:

Bone Marrow Transplantation (2020), Bd. 55, H. 5, S. 884-890

Verlagsangabe:

Nature Publishing Group

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1038/s41409-019-0742-7

ISSN:

1476-5365